Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA) Read more
Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform Read more
PURIFY’22 to Address Challenges, Opportunities and Full-scale Application of Chromatography to Future Manufacturing, Opines S. K. Jana, Director R&D and Manufacturing, Serum Institute Read more
Reuters Digital Health forum to bring together global leaders on the transformative potential of technology in healthcare Read more
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency Read more